Robin L. Blumenthal

1.2k total citations · 1 hit paper
12 papers, 925 citations indexed

About

Robin L. Blumenthal is a scholar working on Physiology, Dermatology and Epidemiology. According to data from OpenAlex, Robin L. Blumenthal has authored 12 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Dermatology and 3 papers in Epidemiology. Recurrent topics in Robin L. Blumenthal's work include Asthma and respiratory diseases (5 papers), Dermatology and Skin Diseases (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Robin L. Blumenthal is often cited by papers focused on Asthma and respiratory diseases (5 papers), Dermatology and Skin Diseases (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Robin L. Blumenthal collaborates with scholars based in United States, Indonesia and Canada. Robin L. Blumenthal's co-authors include Steven P. Balk, Steven B. Landau, Kai W. Wucherpfennig, Ellen C. Ebert, Richard S. Blumberg, Mark Lebwohl, Lawrence F. Eichenfield, Amy S. Paller, Mary Spellman and Adelaide A. Hebert and has published in prestigious journals such as Science, The Journal of Immunology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Robin L. Blumenthal

12 papers receiving 899 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

2016 415 citations Amy S. Paller, Wynnis L. Tom et al. Journal of the American Academy of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin L. Blumenthal United States	8	382	337	331	192	126	12	925
Nordwig S. Tomi Germany	16	538 1.4×	219 0.6×	237 0.7×	130 0.7×	82 0.7×	26	815
Charles F. Schuler United States	12	189 0.5×	224 0.7×	181 0.5×	178 0.9×	66 0.5×	35	628
Raquel Leão Orfali Brazil	15	491 1.3×	321 1.0×	169 0.5×	117 0.6×	51 0.4×	44	691
Sarah Thunberg Sweden	15	336 0.9×	658 2.0×	619 1.9×	724 3.8×	44 0.3×	21	1.4k
Susan Tofte United States	14	1.1k 2.8×	859 2.5×	165 0.5×	418 2.2×	62 0.5×	19	1.3k
Tobias Hagemann Germany	9	797 2.1×	660 2.0×	268 0.8×	329 1.7×	53 0.4×	19	1.1k
Hartmut Ständer Germany	17	514 1.3×	182 0.5×	78 0.2×	77 0.4×	111 0.9×	32	743
Steven E. Prawer United States	14	406 1.1×	84 0.2×	197 0.6×	51 0.3×	310 2.5×	23	825
Rongfei Zhu China	15	249 0.7×	451 1.3×	132 0.4×	395 2.1×	25 0.2×	70	693
Elena Crestani United States	13	98 0.3×	385 1.1×	218 0.7×	344 1.8×	33 0.3×	26	909

Countries citing papers authored by Robin L. Blumenthal

Since Specialization

Citations

This map shows the geographic impact of Robin L. Blumenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin L. Blumenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin L. Blumenthal more than expected).

Fields of papers citing papers by Robin L. Blumenthal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin L. Blumenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin L. Blumenthal. The network helps show where Robin L. Blumenthal may publish in the future.

Co-authorship network of co-authors of Robin L. Blumenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Robin L. Blumenthal. A scholar is included among the top collaborators of Robin L. Blumenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin L. Blumenthal. Robin L. Blumenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Paller, Amy S., Wynnis L. Tom, Mark Lebwohl, et al.. (2016). Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. Journal of the American Academy of Dermatology. 75(3). 494–503.e6. 415 indexed citations breakdown →

Boguniewicz, Mark, Amy S. Paller, Wynnis L. Tom, et al.. (2016). Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 137(2). AB397–AB397. 3 indexed citations

Paller, Amy S., Wynnis L. Tom, Mark Lebwohl, et al.. (2016). Two phase 3 studies in atopic dermatitis with crisaborole, the novel, nonsteroidal topical phosphodiesterase 4 inhibitor. 33. 2 indexed citations

Zane, Lee T., Amy S. Paller, Wynnis L. Tom, et al.. (2016). Two phase 3 study results of children and adults with mild-to-moderate atopic dermatitis treated with Crisaborole Topical Ointment, 2%, a novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase 4 inhibitor. The Journal of Immunology. 196(1_Supplement). 191.26–191.26. 1 indexed citations

Lal, Ritu, Juthamas Sukbuntherng, Wendy Luo, et al.. (2011). Clinical Pharmacokinetics of Gabapentin After Administration of Gabapentin Enacarbil Extended-Release Tablets in Patients With Varying Degrees of Renal Function Using Data From an Open-Label, Single-Dose Pharmacokinetic Study. Clinical Therapeutics. 34(1). 201–213. 26 indexed citations

Lal, Ritu, et al.. (2010). Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine. British Journal of Clinical Pharmacology. 69(5). 498–507. 38 indexed citations

Huff, F. Jacob, Ritu Lal, Juthamas Sukbuntherng, et al.. (2008). Clinical Evaluation of Xp19986 as a Potential Treatment for GERD. The American Journal of Gastroenterology. 103. S11–S11. 3 indexed citations

Blumenthal, Robin L., Dianne E. Campbell, Paul S. Hwang, et al.. (2001). Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. Journal of Allergy and Clinical Immunology. 107(2). 258–264. 64 indexed citations

Tsitoura, Daphne, Robin L. Blumenthal, Gerald J. Berry, Rosemarie H. DeKruyff, & Dale T. Umetsu. (2000). Mechanisms preventing allergen-induced airways hyperreactivity: Role of tolerance and immune deviation. Journal of Allergy and Clinical Immunology. 106(2). 239–246. 76 indexed citations

10.

Bernardo, John, et al.. (1998). Differential Responses of Human Mononuclear Phagocytes to Mycobacterial Lipoarabinomannans: Role of CD14 and the Mannose Receptor. Infection and Immunity. 66(1). 28–35. 69 indexed citations

11.

Berman, Jeffrey S., Robin L. Blumenthal, Hardy Kornfeld, et al.. (1996). Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. The Journal of Immunology. 156(10). 3828–3835. 22 indexed citations

12.

Balk, Steven P., Ellen C. Ebert, Robin L. Blumenthal, et al.. (1991). Oligoclonal Expansion and CD1 Recognition by Human Intestinal Intraepithelial Lymphocytes. Science. 253(5026). 1411–1415. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact